Shares of First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation (LON:FBT – Get Free Report) traded down 0.3% during trading on Tuesday . The company traded as low as GBX 1,418.84 ($17.66) and last traded at GBX 1,430.60 ($17.81). 10,238 shares traded hands during trading, an increase of 686% from the average session volume of 1,303 shares. The stock had previously closed at GBX 1,435.50 ($17.87).
First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation Trading Down 0.8 %
The stock has a market cap of £4.15 billion and a P/E ratio of -1,275.45. The company has a current ratio of 9.42, a quick ratio of 9.27 and a debt-to-equity ratio of 0.04. The stock’s fifty day moving average price is GBX 1,461.01 and its 200 day moving average price is GBX 1,442.51.
First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation Company Profile
Forbidden Technologies plc develops and owns cloud-based video technology in the United Kingdom, North America, and internationally. It offers Forscene, a cloud based video post-production and publishing platform with various applications, such as editing, adding closed caption, graphics, metadata fast, remote viewing, collaboration, and publishing content.
Featured Stories
- Five stocks we like better than First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation
- Do Real Estate Investment Trusts Deserve a Place in Your Portfolio?
- Comprehensive PepsiCo Stock Analysis
- Trading Stocks: RSI and Why it’s Useful
- CSX Co.: The Railroad Powering Ahead with an Earnings Beat
- Investing in Commodities: What Are They? How to Invest in Them
- 3 Steel Stocks Could Soar on New China Tariffs
Receive News & Ratings for First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation and related companies with MarketBeat.com's FREE daily email newsletter.